Person
Paul Flatau
Affiliation:
ORCID:
Discussion paper
Capturing the economic value of psychosocial support: a discussion paper
This discussion paper examines psychosocial support in Australia’s mental health system and the economic evidence of its impact. While emerging findings indicate mental, social, and economic benefits, robust evaluation remains limited. Gaps include definitions, frameworks, and system-level data. The paper calls for investment in measurement, mapping, and economic evaluation to strengthen evidence and inform reform.
Report
The state of the social economy in Australia
A world where economies are measured by the extent to which they generate positive social and environmental outcomes is being shaped around the globe by the social economy. This first comprehensive research into Australia’s social economy explores key areas including funding, partnerships, impact measurement, legal and policy frameworks, and digital technologies.
Discussion paper
Reviving the great Australian dream: homeownership & housing security for all
A series of policy provocations on how policymakers can more effectively address the housing supply and affordability crisis in Australia. Contribution themes include housing security, opening the window to housing for all and a fresh look at the Australian housing dream.
Report
Australian tech giving report 2025
The first comprehensive benchmark of personal philanthropy in Australia’s technology sector, this report finds the sector uniquely positioned to unlock a new era of giving in Australia. This community is more likely to give, give more and give differently. Tech givers often applying entrepreneurial principles to their philanthropy.
Report
Good Sammy open employment trials
Good Sammy Enterprises (GSE) is a not-for-profit social enterprise in Western Australia. GSE is trialling new models of employment support to people with intellectual disability to build their capacity and secure open employment outside GSE. This interim report evaluates the impact, outcomes and effectiveness of the trials.